Observational studyJournal of clinical hypertension (Greenwich, Conn.)2016

Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry.

Iris Kistner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.